Joshua Holzer, a Partner with StoneTurn, brings more than 20 years of public and private sector experience in compliance, risk assessment and mitigation, and investigations. As an international trade expert, Joshua draws on his work as in-house counsel, in government, and in private practice to help clients proactively and reactively design innovative solutions to identify and manage risk.
Skilled at developing and implementing compliance solutions for a global business environment, Joshua offers a unique, practical understanding of international trade laws and regulations, including economic sanctions handled by the U.S. Department of the Treasury’s Office of Foreign Assets Control (OFAC); export controls under the jurisdiction of the U.S. Department of Commerce’s Bureau of Industry and Security (BIS) and the U.S. Department of State’s Directorate of Defense Trade Controls (DDTC); and import matters overseen by U.S. Customs and Border Protection (CBP). He also assists clients in navigating matters involving the U.S. Committee on Foreign Investment in the United States (CFIUS), U.S. national security concerns, and U.S. government contracting. Joshua has created and enhanced compliance programs worldwide; conducted internal investigations; and performed due diligence in connection with complex mergers and acquisitions.
Joshua joined StoneTurn from Pfizer, where he served for nearly a decade as the Chief Counsel for Global Trade. There, he led the design and execution of global compliance protocols to mitigate risks associated with the movement of medicine to more than 175 countries. Joshua also provided primary legal support for the sale and donation of Pfizer vaccines to strategic non-governmental health partners.
A former U.S. government law enforcement official, Joshua held roles at several U.S. government agencies, including the U.S. Departments of Homeland Security (DHS), Commerce (DOC), and Justice (DOJ), and the U.S. General Services Administration. In these roles, he focused on the enforcement of export controls and economic sanctions laws, and led investigations to promote integrity and efficiency, and deter fraud in U.S. government operations. In private practice, Joshua represented domestic and international companies, on regulatory and criminal matters related to a wide variety of government investigations and enforcement actions.
A Certified Fraud Examiner (CFE), Joshua is a member of the New York State and District of Columbia bars. He has received several awards for his work, including Pfizer’s first General Counsel Award for Innovation, the U.S. Department of Commerce’s Gold Medal Award for Distinguished Performance, and Special Service Awards from the Inspector General at both the U.S. Department of Justice and the U.S. General Services Administration.